AR054857A1 - Derivados de n- (heteroaril)-1- heteroarilquil-1 h - indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica - Google Patents
Derivados de n- (heteroaril)-1- heteroarilquil-1 h - indol-2- carboxamidas, su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- AR054857A1 AR054857A1 ARP060103167A ARP060103167A AR054857A1 AR 054857 A1 AR054857 A1 AR 054857A1 AR P060103167 A ARP060103167 A AR P060103167A AR P060103167 A ARP060103167 A AR P060103167A AR 054857 A1 AR054857 A1 AR 054857A1
- Authority
- AR
- Argentina
- Prior art keywords
- aryl
- alkyl
- cycloalkyl
- alkylene
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procedimiento de preparacion y aplicacion en terapéutica. Reivindicacion 1: Un compuesto que responde a la formula (1), en la que: X1, X2, X3, X4 representan, independientemente uno de otro, un átomo de hidrogeno o de halogeno o un grupo alquilo C1- 6, cicloalquilo C3-7, cicloalquilC3-7-alquilenoC1-3, fluoroalquilo C1-6, alcoxilo C1-6, fluoroalcoxilo C1-6, ciano, C(O)NR1R2, nitro, NR1R2, tioalquilo C1-6, -S(O)-alquiloC1-6, -S(O)2-alquiloC1-6, SO2NR1R2, NR3COR4, NR3SO2R5 o arilo, estando el arilo opcionalmente sustituido con uno o varios sustituyentes elegidos entre un halogeno, un grupo alquilo C1-6, cicloalquilo C3-7, cicloalquilC3-7-alquilenoC1-3, fluoroalquilo C1-6, alcoxilo C1-6, fluoroalcoxilo C1-6, nitro o ciano; W representa un grupo bicíclico fusionado de la formula (2), unido al átomo de nitrogeno por las posiciones 1, 2, 3 o 4; A representa un heterociclo de 5 a 7 eslabones que comprende de uno a tres heteroátomos elegidos entre O, S o N; estando el o los átomos de carbono de A opcionalmente sustituidos con uno o varios grupos elegidos entre un átomo de hidrogeno o un grupo alquilo C1-6, cicloalquilo C3-7, cicloalquilC3-7-alquilenoC1-3, fluoroalquilo C1-6, arilo, aril-alquilenoC1-6, oxo o tio; estando el o los átomos de nitrogeno de A opcionalmente sustituidos con R6 cuando el nitrogeno es adyacentes a un átomo de carbono sustituido con un grupo oxo, o con R7 en los otros casos; n es igual a 1, 2 o 3; Y representa un heteroarilo opcionalmente sustituido con uno o varios grupos elegidos entre un átomo de halogeno o un grupo alquilo C1-6, cicloalquilo C3-7, cicloalquilC3-7-alquilenoC1-3, fluoroalquilo C1-6, hidroxilo, alcoxilo C1-6, fluoroalcoxilo C1-6, ciano, C(O)NR1R2, tioalquilo C1-6, SH, -S(O)- alquiloC1-6, -S(O)2-alquiloC1-6, SO2NR1R2, NR3COR4, NR3SO2R5, aril-alquilenoC1-6 o arilo, estando el arilo y el aril-alquilenoC1-6 opcionalmente sustituidos con uno o varios sustituyentes elegidos entre un halogeno, un grupo alquilo C1-6, cicloalquilo C3-7, cicloalquilC3-7-alquilenoC1-3, fluoroalquilo C1-6, alcoxilo C1-6, fluoroalcoxilo C1-6, nitro o ciano; R1 y R2, representan, independientemente uno de otro, un átomo de hidrogeno o un grupo alquilo C1-6, cicloalquilo C3-7, cicloalquil3-7-alquilenoC1-3, aril-alquilenoC1-6 o arilo; o R1 y R2 forman conjuntamente, con el átomo de nitrogeno que les lleva, un grupo azetidinilo, pirrolidinilo, piperidinilo, azepinilo, morfolinilo, tiomorfolinilo, piperazinilo, homopiperazinilo, estando este grupo opcionalmente sustituido con un grupo alquilo C1-6, cicloalquilo C3-7, cicloalquilC3-7-alquilenoC1-3-, aril-alquileno C1-6 o arilo; R3 y R4 representan, independientemente uno de otro, un átomo de hidrogeno o un grupo alquilo C1-6, aril-alquilenoC1-6 o arilo; R5 representa un grupo alquilo C1-6, aril-alquilenoC1-6 o arilo; R6 representa un átomo de hidrogeno o un grupo alquilo C1-6, cicloalquilo C3-7, cicloalquilC3-7-alquilenoC1-3, fluoroalquilo C1-6, aril- alquilenoC1-6 o arilo; R7 representa un átomo de hidrogeno o un grupo alquilo C1-6, cicloalquilo C3-7, cicloalquilC3-7-alquilenoC1-3, fluoroalquilo C1-6, aril-alquilenoC1-6, alquilC1-6-C(O)-, cicloalquilC3-7-alquilenC1-3-(CO)-, fluoroalquilC1-6-C(O)- , cicloalquilC3-7-C(O)-, aril-C(O)-, aril-alquilenC1-6-C(O)-, alquilC1-6-S(O)2-, fluoroalquilC1-6-S(O)2-, cicloalquilC3-7-S(O)2-, cicloalquilC3-7-alquilenC1-3-S(O)2-, aril-S(O)2-, o aril-alquilenC1-6-S(O)2- o arilo; pudiendo estar el o los átomos de azufre del heterociclo A o del heterociclo Y en forma oxidada; pudiendo estar el o los átomos de nitrogeno del heterociclo A o del heteroarilo Y en forma oxidada; en el estado de base o de sal de adicion de ácido, así como en el estado de hidrato o de solvato.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0507803A FR2888847B1 (fr) | 2005-07-22 | 2005-07-22 | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054857A1 true AR054857A1 (es) | 2007-07-18 |
Family
ID=36156910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060103167A AR054857A1 (es) | 2005-07-22 | 2006-07-21 | Derivados de n- (heteroaril)-1- heteroarilquil-1 h - indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica |
Country Status (27)
Country | Link |
---|---|
US (3) | US7745467B2 (es) |
EP (1) | EP1910335B1 (es) |
JP (1) | JP5281890B2 (es) |
KR (1) | KR20080027864A (es) |
CN (1) | CN101228152B (es) |
AR (1) | AR054857A1 (es) |
AU (1) | AU2006271524B2 (es) |
BR (1) | BRPI0613758A2 (es) |
CA (1) | CA2615751C (es) |
CR (1) | CR9590A (es) |
EA (1) | EA013748B1 (es) |
EC (1) | ECSP088084A (es) |
FR (1) | FR2888847B1 (es) |
HK (1) | HK1123050A1 (es) |
IL (1) | IL188643A (es) |
MA (1) | MA29698B1 (es) |
MX (1) | MX2008001019A (es) |
MY (1) | MY146545A (es) |
NI (1) | NI200800015A (es) |
NO (1) | NO20080871L (es) |
NZ (1) | NZ565148A (es) |
TN (1) | TNSN07469A1 (es) |
TW (1) | TWI386402B (es) |
UA (1) | UA93687C2 (es) |
UY (1) | UY29690A1 (es) |
WO (1) | WO2007010144A1 (es) |
ZA (1) | ZA200800438B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1314733A1 (en) * | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
FR2888847B1 (fr) | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
EP2079466B1 (en) * | 2006-09-29 | 2014-01-15 | GlaxoSmithKline LLC | Substituted indole compounds |
FR2911605B1 (fr) * | 2007-01-19 | 2009-04-17 | Sanofi Aventis Sa | Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique |
FR2911604B1 (fr) * | 2007-01-19 | 2009-04-17 | Sanofi Aventis Sa | Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
FR2919610B1 (fr) * | 2007-08-02 | 2009-10-16 | Sanofi Aventis Sa | Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique |
AU2008286946B2 (en) * | 2007-08-10 | 2013-11-21 | H. Lundbeck A/S | Heteroaryl amide analogues |
FR2926555B1 (fr) * | 2008-01-22 | 2010-02-19 | Sanofi Aventis | Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique |
FR2926556B1 (fr) * | 2008-01-22 | 2010-02-19 | Sanofi Aventis | Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique |
FR2926554B1 (fr) * | 2008-01-22 | 2010-03-12 | Sanofi Aventis | Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique |
FR2926553B1 (fr) * | 2008-01-23 | 2010-02-19 | Sanofi Aventis | Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique |
US8309581B2 (en) * | 2009-09-29 | 2012-11-13 | Hoffmann-La Roche Inc. | Benzimidazole derivatives |
JP6331882B2 (ja) * | 2014-08-28 | 2018-05-30 | ソニー株式会社 | 送信装置、送信方法、受信装置および受信方法 |
WO2024026290A1 (en) * | 2022-07-25 | 2024-02-01 | Cayman Chemical Company Incorporated | NOVEL HETEROCYCLES AS sPLA2-X INHIBITORS |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852046A (en) | 1993-08-03 | 1998-12-22 | Hoechst Aktiengesellschaft | Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them |
SE9903998D0 (sv) | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
DE10147672A1 (de) | 2001-09-27 | 2003-04-10 | Bayer Ag | Substituierte 2,5-Diamidoindole und ihre Verwendung |
EP1314733A1 (en) * | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
EP2033953A1 (en) * | 2002-02-15 | 2009-03-11 | Glaxo Group Limited | Vanilloid receptor modulators |
US20060183753A1 (en) | 2002-12-20 | 2006-08-17 | Bayer Healthcare Ag | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
ATE450533T1 (de) * | 2003-02-14 | 2009-12-15 | Glaxo Group Ltd | Carboxamidderivate |
EP1479677A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | New indole derivatives as factor xa inhibitors |
FR2874015B1 (fr) * | 2004-08-05 | 2006-09-15 | Sanofi Synthelabo | Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
FR2880625B1 (fr) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
FR2888848B1 (fr) | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
FR2888847B1 (fr) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
FR2911604B1 (fr) * | 2007-01-19 | 2009-04-17 | Sanofi Aventis Sa | Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
-
2005
- 2005-07-22 FR FR0507803A patent/FR2888847B1/fr active Active
-
2006
- 2006-07-20 NZ NZ565148A patent/NZ565148A/en not_active IP Right Cessation
- 2006-07-20 BR BRPI0613758-0A patent/BRPI0613758A2/pt not_active Application Discontinuation
- 2006-07-20 UA UAA200802260A patent/UA93687C2/ru unknown
- 2006-07-20 EP EP06778898.4A patent/EP1910335B1/fr active Active
- 2006-07-20 ZA ZA200800438A patent/ZA200800438B/xx unknown
- 2006-07-20 CN CN2006800266935A patent/CN101228152B/zh not_active Expired - Fee Related
- 2006-07-20 JP JP2008522023A patent/JP5281890B2/ja not_active Expired - Fee Related
- 2006-07-20 AU AU2006271524A patent/AU2006271524B2/en not_active Ceased
- 2006-07-20 WO PCT/FR2006/001782 patent/WO2007010144A1/fr active Application Filing
- 2006-07-20 KR KR1020087001596A patent/KR20080027864A/ko not_active Application Discontinuation
- 2006-07-20 MY MYPI20063488A patent/MY146545A/en unknown
- 2006-07-20 EA EA200800403A patent/EA013748B1/ru not_active IP Right Cessation
- 2006-07-20 CA CA2615751A patent/CA2615751C/fr not_active Expired - Fee Related
- 2006-07-20 MX MX2008001019A patent/MX2008001019A/es active IP Right Grant
- 2006-07-21 AR ARP060103167A patent/AR054857A1/es unknown
- 2006-07-21 UY UY29690A patent/UY29690A1/es unknown
- 2006-07-21 TW TW095126729A patent/TWI386402B/zh not_active IP Right Cessation
-
2007
- 2007-12-12 TN TNP2007000469A patent/TNSN07469A1/en unknown
- 2007-12-13 CR CR9590A patent/CR9590A/es not_active Application Discontinuation
-
2008
- 2008-01-07 IL IL188643A patent/IL188643A/en not_active IP Right Cessation
- 2008-01-08 US US11/970,878 patent/US7745467B2/en not_active Expired - Fee Related
- 2008-01-09 EC EC2008008084A patent/ECSP088084A/es unknown
- 2008-01-17 NI NI200800015A patent/NI200800015A/es unknown
- 2008-02-12 MA MA30646A patent/MA29698B1/fr unknown
- 2008-02-19 NO NO20080871A patent/NO20080871L/no not_active Application Discontinuation
-
2009
- 2009-01-13 HK HK09100335.5A patent/HK1123050A1/xx not_active IP Right Cessation
-
2010
- 2010-05-11 US US12/777,846 patent/US8318775B2/en not_active Expired - Fee Related
-
2012
- 2012-10-23 US US13/658,412 patent/US8735432B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR054857A1 (es) | Derivados de n- (heteroaril)-1- heteroarilquil-1 h - indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica | |
AR064937A1 (es) | Derivados de n-(heteroaril)-1-heteroaril-1h-indol-2-carboxamidas, su preparacion y su aplicacion en terapeutica | |
AR061946A1 (es) | Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas, su preparacion y composiciones farmaceuticas | |
AR052450A1 (es) | Derivados de n-(heteroaril)-1h- indol-2-carboxamidas , supreparacion y su aplicacion en terapeutica | |
AR057668A1 (es) | Derivados de n-(arilalquil)-1h-pirrolopiridin-2-carboxamidas, su preparacion, composiciones farmaceuticas y su aplicacion en terapeutica | |
AR062143A1 (es) | Derivados de n-(amino- heteroaril)-1h-indol-2-carboxamidas y un procedimiento de preparacion | |
AR070207A1 (es) | Derivados biciclicos de carboxamidas aza- biciclicas su preparacion y su aplicacion terapeutica | |
ECSP077215A (es) | Derivados de n-(1h-indolil)-1h-indol-2-carboxamidas, su preparación y su aplicación en terapéutica | |
AR064524A1 (es) | Derivados de n-(amino-(hetero)aril)-1h-pirrolopiridin-2-carboxamidas, su preparacion, intermediarios para su sintesis, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por los receptores de tipo trpv1. | |
ES2297727T3 (es) | Derivados de octahidropirrolo(3,4-c)pirrol y su empleo como agentes antiviricos. | |
AR061642A1 (es) | Derivados de ureas de tropano, su preparacion y su aplicacion en terapeu-tica, procesos de obtencion y composiciones farmaceuticas | |
CO5721001A2 (es) | Derivados sustituidos de morfolina y tiomorfolina | |
NI200900037A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-alfa] piridinas, su preparación y su aplicación en terapéutica. | |
AR066669A1 (es) | Derivados de imidazolona como inhibidores de bencimidazolona quimasa. composiciones farmaceuticas. | |
CO6251251A2 (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
CO5690582A2 (es) | Derivados de n-tiazol-2-il-benzamida | |
AR072016A1 (es) | Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato | |
CO6150150A2 (es) | Derivados de 7-alquinil-1,8-naftiridonas su prepacion y su aplicacion en terapeutica | |
AR066107A1 (es) | Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen. | |
AR055744A1 (es) | Derivados de acido pirimidincarboxilico, su uso para preparar medicamentos y preparacion de dicjhos compuestos | |
NI200600279A (es) | Derivados de tetrahidroisoquinolilsulfonamidas, su preparación y su utilización en terapéutica | |
AR066605A1 (es) | Derivados de heteroarilamida pirimidona | |
CO6150147A2 (es) | Derivados de 5,6-bisaril-2-piridin-carboxamida su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii | |
AR066603A1 (es) | Derivados de arilamida pirimidona | |
AR058110A1 (es) | Derivados de piperidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |